The rise and fall over the first fifty years of plant chemosystematics, emp
loying secondary products, is outlined here. The retention of some degree o
f activity in this field is recommended, especially with the flavonoids tha
t are of universal occurrence. This is not only to further refine systems o
f plant classification below the family level, but also to map the still la
rgely uncharted territory of bioactive metabolites in plants. Almost every
plant species has a unique collection of secondary constituents distributed
throughout its tissues, a proportion of which is likely to respond positiv
ely to an appropriate medical bioassay. The success of the chemosystematic
approach to the search for a renewable source of taxol, the anti-cancer dru
g from Taxus brevifolia, is described.